Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)

• Company Description    HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Number of Employees: 459

• Price / Volume Information    Yesterday's Closing Price: $6.06 Daily Weekly Monthly 20 Day Moving Average: 132,245 shares Shares Outstanding: 40.81 (millions) Market Capitalization: $247.31 (millions) Beta: 1.75 52 Week High: $8.75 52 Week Low: $3.87 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.40% -12.21% 12 Week -12.93% -15.13% Year To Date -14.04% -12.14%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 OCTOBER HILL RD - HOLLISTON,MA 01746 USA ph: 508-893-8999 fax: 508-429-5732 info@harvardbioscience.com http://www.harvardbioscience.com

• General Corporate Information    Officers James Green - Chief Executive Officer and Director Michael A. Rossi - Chief Financial Officer Katherine A. Eade - Director Alan Edrick - Director John F. Kennedy - Director Peer Information Harvard Bioscience, Inc. (DNEX) Harvard Bioscience, Inc. (T.PUR) Harvard Bioscience, Inc. (CALP) Harvard Bioscience, Inc. (CCSI.) Harvard Bioscience, Inc. (NEWP.) Harvard Bioscience, Inc. (MTD) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INSTRU-SCIENTFC Sector: Computer and Technology CUSIP: 416906105 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/21 Next Expected EPS Date: 03/09/22 Share - Related Items Shares Outstanding: 40.81 Most Recent Split Date: (:1) Beta: 1.75 Market Capitalization: $247.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.30 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/09/22

• Fundamental Ratios P/E Current FY Estimate: 20.20 Trailing 12 Months: 35.65 PEG Ratio: - Price Ratios Price/Book: 3.21 Price/Cash Flow: 19.95 Price / Sales: 2.12 EPS Growth vs. Year Ago Period: 300.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 23.41% vs. Previous Quarter: 1.60% ROE 12/31/21 - - 09/30/21 - 9.59 06/30/21 - 8.03 ROA 12/31/21 - - 09/30/21 - 4.82 06/30/21 - 4.07 Current Ratio 12/31/21 - - 09/30/21 - 2.37 06/30/21 - 2.30 Quick Ratio 12/31/21 - - 09/30/21 - 1.26 06/30/21 - 1.24 Operating Margin 12/31/21 - - 09/30/21 - 6.35 06/30/21 - 5.59 Net Margin 12/31/21 - - 09/30/21 - -1.60 06/30/21 - -2.51 Pre-Tax Margin 12/31/21 - - 09/30/21 - -1.56 06/30/21 - -2.95 Book Value 12/31/21 - - 09/30/21 - 1.89 06/30/21 - 1.93 Inventory Turnover 12/31/21 - - 09/30/21 - 2.13 06/30/21 - 2.09 Debt-to-Equity 12/31/21 - - 09/30/21 - 0.56 06/30/21 - 0.52 Debt-to-Capital 12/31/21 - - 09/30/21 - 35.73 06/30/21 - 34.21

Powered by Zacks Investment Research ©